Antidepressants and quality of life in patients with major depressive disorder – Systematic review and meta‐analysis of double‐blind, placebo‐controlled RCTs
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antidepressants and quality of life in patients with major depressive disorder – Systematic review and meta‐analysis of double‐blind, placebo‐controlled RCTs
Authors
Keywords
-
Journal
ACTA PSYCHIATRICA SCANDINAVICA
Volume 147, Issue 6, Pages 545-560
Publisher
Wiley
Online
2023-03-11
DOI
10.1111/acps.13541
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combining Antidepressants vs Antidepressant Monotherapy for Treatment of Patients With Acute Depression
- (2022) Jonathan Henssler et al. JAMA Psychiatry
- Dose effects of tricyclic antidepressants in the treatment of acute depression – A systematic review and meta-analysis of randomized trials
- (2022) Christopher Baethge et al. JOURNAL OF AFFECTIVE DISORDERS
- Antidepressants and health-related quality of life (HRQoL) for patients with depression: Analysis of the medical expenditure panel survey from the United States
- (2022) Omar A. Almohammed et al. PLoS One
- Dose-Response Relationship in Selective Serotonin and Norepinephrine Reuptake Inhibitors in the Treatment of Major Depressive Disorder: A Meta-Analysis and Network Meta-Analysis of Randomized Controlled Trials
- (2021) Lena Rink et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Concordance between clinician-rated and patient reported outcome measures of depressive symptoms in treatment resistant depression
- (2020) Rachel Hershenberg et al. JOURNAL OF AFFECTIVE DISORDERS
- Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
- (2020) Fiammetta Cosci et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- In search of a dose–response relationship in SSRIs—a systematic review, meta‐analysis, and network meta‐analysis
- (2020) C. Braun et al. ACTA PSYCHIATRICA SCANDINAVICA
- Withdrawal Confounding in Randomized Controlled Trials of Antipsychotic, Antidepressant, and Stimulant Drugs, 2000–2017
- (2019) Alexander M. Récalt et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Antidepressant withdrawal and rebound phenomena
- (2019) Jonathan Henssler et al. Deutsches Arzteblatt International
- Long-Term Acute-Phase Treatment With Antidepressants, 8 Weeks and Beyond
- (2018) Jonathan Henssler et al. JOURNAL OF CLINICAL PSYCHIATRY
- Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review
- (2018) Giovanni A. Fava et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence
- (2017) S. Susan Hedayati et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sertraline for Major Depression During the Year Following Traumatic Brain Injury
- (2017) Jesse R. Fann et al. JOURNAL OF HEAD TRAUMA REHABILITATION
- Effect of psychotherapy for depression on quality of life: meta-analysis
- (2016) Spyros Kolovos et al. BRITISH JOURNAL OF PSYCHIATRY
- Effects of levomilnacipran extended-release on motivation/energy and functioning in adults with major depressive disorder
- (2016) Michael E. Thase et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression
- (2016) Christiane E. Angermann et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Study of the use of antidepressants for depression in dementia: the HTA-SADD trial – a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine
- (2014) S Banerjee et al. HEALTH TECHNOLOGY ASSESSMENT
- Effects of depression co-morbidity and treatment on quality of life in patients with acute coronary syndrome: the Korean depression in ACS (K-DEPACS) and the escitalopram for depression in ACS (EsDEPACS) study
- (2014) J.-M. Kim et al. PSYCHOLOGICAL MEDICINE
- A double-blind, randomized, placebo-controlled study assessing the efficacy and tolerability of desvenlafaxine 10 and 50 mg/day in adult outpatients with major depressive disorder
- (2013) Michael R Liebowitz et al. BMC Psychiatry
- Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/day
- (2013) Jean-Philippe Boulenger et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Changes in well-being and quality of life in a randomized trial comparing dynamic psychotherapy and pharmacotherapy for major depressive disorder
- (2013) Sigal Zilcha-Mano et al. JOURNAL OF AFFECTIVE DISORDERS
- Efficacy and Safety of Desvenlafaxine 50 mg/d in a Randomized, Placebo-Controlled Study of Perimenopausal and Postmenopausal Women With Major Depressive Disorder
- (2013) Anita H. Clayton et al. JOURNAL OF CLINICAL PSYCHIATRY
- Solving the Antidepressant Efficacy Question: Effect Sizes in Major Depressive Disorder
- (2011) Paul A. Vöhringer et al. CLINICAL THERAPEUTICS
- Symptomatic and Functional Improvement in Employed Depressed Patients
- (2011) Boadie W. Dunlop et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- The Impact of Psychotherapy, Pharmacotherapy, and Their Combination on Quality of Life in Depression
- (2011) Waguih William IsHak et al. HARVARD REVIEW OF PSYCHIATRY
- Sertraline for the Treatment of Depression in Alzheimer Disease: Week-24 Outcomes
- (2010) Daniel Weintraub et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Agomelatine in the Treatment of Major Depressive Disorder
- (2010) Stephen M. Stahl et al. JOURNAL OF CLINICAL PSYCHIATRY
- Short-Term Efficacy and Safety of Desvenlafaxine in a Randomized, Placebo-Controlled Study of Perimenopausal and Postmenopausal Women With Major Depressive Disorder
- (2010) Susan G. Kornstein et al. JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy and Safety of Agomelatine in the Treatment of Major Depressive Disorder
- (2010) John Zajecka et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A Randomized Controlled Trial of Sertraline for the Treatment of Depression in Persons With Traumatic Brain Injury
- (2009) Teresa A. Ashman et al. ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
- Effect of Pharmacological Treatment of Depression on A1C and Quality of Life in Low-Income Hispanics and African Americans With Diabetes: A randomized, double-blind, placebo-controlled trial
- (2009) D. Echeverry et al. DIABETES CARE
- Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder
- (2009) Koen Demyttenaere et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Low Doses of Controlled-Release Paroxetine in the Treatment of Late-Life Depression
- (2009) Mark Hyman Rapaport et al. JOURNAL OF CLINICAL PSYCHIATRY
- Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR
- (2009) Karen Hewett et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Double-blind, placebo-controlled evaluation of extended-release bupropion in elderly patients with major depressive disorder
- (2009) K. Hewett et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Quality of Life Measurement in Antidepressant Trials
- (2009) Jürgen De Fruyt et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder
- (2008) Michael R. Liebowitz et al. CURRENT MEDICAL RESEARCH AND OPINION
- Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR
- (2008) K Hewett et al. JOURNAL OF PSYCHOPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search